Press-release for stocks for SNYNF

Prices are updated after-hours

| -9.22% | O: 1.06% H: 0.0% C: 0.0%
train

Rallybio Announces In-Licensing of Potential First-In-Class Preclinical Antibody Candidate from Sanofi
Published: 2022-05-10 (Crawled : 12:00) - biospace.com/
RLYB | News | $1.75 4.79% 4.57% 310K

| -84.01% | O: -7.81% H: 9.95% C: 5.32%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.22% | O: 1.06% H: 0.0% C: 0.0%
preclinical antibody potential sanofi license pre-clinical

Biohaven Reports First Quarter 2022 Financial Results and Reports Recent Business Developments
Published: 2022-05-10 (Crawled : 12:00) - biospace.com/
BHVN | $38.99 -7.52% 0.0% 3.4M

| -55.82% | O: 60.35% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.22% | O: 1.06% H: 0.0% C: 0.0%
results

Global Pharma and Biotech Deal Royalty Rate Report/Directory 2022
Published: 2022-05-10 (Crawled : 11:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.22% | O: 1.06% H: 0.0% C: 0.0%
pharma biotech deal

Roche pledges to extend commitment to the World Federation of Hemophilia Humanitarian Aid Program to 2028
Published: 2022-05-10 (Crawled : 07:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.22% | O: 1.06% H: 0.0% C: 0.0%
program

Innate Pharma Reports First Quarter 2022 Financial Results and Business Update
Published: 2022-05-10 (Crawled : 07:00) - biospace.com/
NVO | News | $122.71 -0.03% 0.17% 5M

| 13.61% | O: -0.53% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M

| -9.22% | O: 1.06% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K

| -9.63% | O: -0.37% H: 2.23% C: 0.93%
pharma results

67%

33%

Save your searches and get alerts when important news are released.